PET Imaging of Patients With Melanoma and Malignant Brain Tumors Using an 124I-labeled cRGDY Silica Nanomolecular Particle Tracer: A Microdosing Study

Clinical trial NCT01266096 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT01266096
Sponsor: Memorial Sloan Kettering Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Newly Diagnosed or Recurrent Metastatic Melanoma Patients Malignant Brain Tumors

Start date: 2011-01-01
Primary completion: 2026-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.